Effect of L-carnitine in carpal tunnel syndrome

Phase 3

• Conditions: Carpal tunnel syndrome.; Carpal tunnel syndrome; G56.0

• Registration Number: IRCT20200307046711N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Parsons who there CTS is confirmed by electrodiagnostic study and clinical signe and symptoms
Patients who aged 18 to 65 years old

Exclusion Criteria

Diseases such as diabetes mellitus, hypothyroidism, rheumatologic diseases, end stage renal disease
Patients who use chemotherapy drugs or any drug that cause neuropathy
Pregnant or breast feeding women
History of seizure
Bon mass index > 40 or <18
History of drug allergy
Uncontrolled blood pressure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Electrodiagnostic parameters. Timepoint: Before intervention, 4 then 6 weeks after onset. Method of measurement: Electrodiagnostic instruments.;Hand pain and function. Timepoint: before intervention, 4 then 6 weeks after onset. Method of measurement: Boston questioner.;Cross sectional area of median nerve at wrist. Timepoint: Before intervention, 4 then 6 weeks after onset. Method of measurement: Sonography instrument.